2004 Fiscal Year Final Research Report Summary
Developmental research of new generation DNA vaccine against microorganism using synthesized DNA
Project/Area Number |
15390145
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Bacteriology (including Mycology)
|
Research Institution | YOKOHAMA CITY UNIVERSITY |
Principal Investigator |
OKUDA Kenji YOKOHAMA CITY UNIVERSITY, GRADUATE SCHOOL OF MEDECINE, PROFESSOR, 大学院・医学研究科, 教授 (40124862)
|
Co-Investigator(Kenkyū-buntansha) |
島田 勝 横浜市立大学, 医学部, 講師 (40301452)
HAMAJIMA Kenji YOKOHAMA CITY UNIVERSITY, SCHOOL OF MEDECINE, ASSISTANT PROFESSOR, 医学部, 助手 (00114611)
|
Project Period (FY) |
2003 – 2004
|
Keywords | DNA vaccine / Virus vector / pseudomonas / HIV / El deficient adeno virus / adeno 5 / 35 virus / influenza virus |
Research Abstract |
In this study, we studied the importance of preventive DNA vaccine and virus vector vaccine against microbe infectious diseases. We constructed three types of DNA vaccine of pseudomonas containing Opr F/I, Pcr V and Pill genes. After immunization to mice with each or the combination of DNA vaccine, the mice were challenged with D1 strain. When immunized with the combination of three vaccines, more than 90% of the mice were survived. The preventive effect was high in order of Pcr V, OprF/I and Pili. Non immunized mice died 2 days later after challenging. Therefore, the vaccines which we constructed have strong effects to prevent infection and we confirmed that Pcr V worked as strong preventive antigen. On the other hand, to observe preventive effects against HIV-1, we developed a new DNA vector which the genes of Gag-Pal and Env were inserted into CAG promoter and an E1 deficient adeno 5/35 virus vector which the fiber of adeno virus type 5 replaced into the fiber of adeno type35. After immunization using these novel vaccines, we challenged monkeys with SHIV89.6. At the group which were immunized with DNA vaccine+Ad5/35, the viral load kept under the detectable level up to 25th weeks. Former adeno virus vector of type 5 had some faults such as liver obstacle. However, it became clear that Ad5/35 vector was best for human. From these results, we are going to develop more convenient immunizing route of pseudomonas vaccine for clinical trial. On HIV-1, we are planning to join with some pharmaceutical companies to do phase I clinical trial. Furthermore, we hope to develop other best DNA vaccines or virus vector vaccines against severe infectious diseases such as O-157 or Ave influenza using Ad5/35 vector.
|
Research Products
(40 results)
-
-
-
-
-
-
-
-
[Journal Article] Repair of articular cartilage defect by autologous transplantation of basic fibroblast growth factor gene-transduced chondrocytes with adeno-associated virus vector2005
Author(s)
Yokoo, N., Saito, T., Uesugi, M., Kobayashi, N., Xin, K.-Q., Okuda, K., Mizukami, H., Ozawa, K., Koshino, T.
-
Journal Title
Arthritis Rheum 52
Pages: 164-170
Description
「研究成果報告書概要(欧文)」より
-
[Journal Article] Combination of DNA vaccine and adenovirus vector by cutaneous administration induced strong HIV-specific cellular immune responses in mice2005
Author(s)
Takakura, M., Okuda, K., Matsuda, T., Takeshita, F., Takakura, H., Ikezawa, Z, Xin, K.-Q.
-
Journal Title
Vaccine 23
Pages: 847-848
Description
「研究成果報告書概要(欧文)」より
-
[Journal Article] Vaccination of rhesus macaques with recombinant mycobacterium bovis calmette-guerin env V3 elicites neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif2005
Author(s)
Someya, K., Cecilia, D., Ami, Y., Nakasone, T., Matsuo, K., Burda, S., Yamamoto, H., Yoshino, N., Kaizu, M., Ando, S., Okuda, K., Zolla-Pazner, S., Yamazaki, S., Yamamoto, N., Honda, M.
-
Journal Title
J Virol. 79
Pages: 1452-1462
Description
「研究成果報告書概要(欧文)」より
-
-
[Journal Article] Therapeutic effect of CpG-enriched plasmid administration on the tight-skin mouse model of scleroderma2005
Author(s)
Shen, Y., Ichino, M., Nakazawa, M., Ikejima, T., Kojima, Y., Okuda, K., Minami, M.
-
Journal Title
J Autoimmune 24
Pages: 183-190
Description
「研究成果報告書概要(欧文)」より
-
-
-
-
-
-
-
-
-
[Journal Article] Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice2004
Author(s)
Shinoda, K., Xin, K.-Q., Johna, I.N., Kojima, Y., Tamura, Y., Okada, E., Kawamoto, S., Okuda, K., Klinman, D., Okuda, K.
-
Journal Title
Vaccine 22
Pages: 3676-3690
Description
「研究成果報告書概要(欧文)」より
-
[Journal Article] Improvement of DNA vaccine immunogenicity by a dual antigen expression system2004
Author(s)
Sasaki, S., Takeshita, F., Oikawa, T., Kojima, Y., Xin, K.-Q., Okuda, K., Ishii, N.
-
Journal Title
Biochem Biophys Res Commun 315
Pages: 38-43
Description
「研究成果報告書概要(欧文)」より
-
[Journal Article] consecutive prime-boost vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus DIs elicits effective anti-SIV immunity. A consecutive prime-boost vaccination of mice with simian immunodeficiency virus (SIV) gag/pal DNA and recombinant vaccinia virus DIs elicits effective anti-SIV immunity2004
Author(s)
Someya, K., Xin K.-Q., Matsuo, K., Okuda, K., Yamamoto, N., Honda, M.
-
Journal Title
J Virol 78
Pages: 9842-9853
Description
「研究成果報告書概要(欧文)」より
-
[Journal Article] Intranasal HIV-1-gp160-DNA/gp41 peptide prime-boost immunization regimen in mice results in long-term HIV-1 neutralizing humoral mucosal and systemic immunity2004
Author(s)
Devito, C., Zuber, B., Schroder, U., Benthin, R., Okuda, K., Broliden, K., Wahren, B., Hinkula, J.
-
Journal Title
J Immunol 173
Pages: 7078-7089
Description
「研究成果報告書概要(欧文)」より
-
-
[Journal Article] Construction and immunogenicity study of a 297-bp humanized HIV V3 DNA of an approximated last common ancestor in mice2004
Author(s)
Sirivichayakul, S., Tirawatnapong, T., Ruxrungtham, K., Oelrichs, R., Lorenzen, S.L., Xin, K.-Q., Okuda, K., Phanuphak, P.
-
Journal Title
Asian Pac J Allergy Immunol. 22
Pages: 49-60
Description
「研究成果報告書概要(欧文)」より
-
[Journal Article] Genetic immunization with multiple HIV-1 genes provides protection against HIV-1/MuL V pseudovirus challenge in vivo2004
Author(s)
Hinkula, J., Rollman, E., Lundholm, P., Benthin, R.M., Okuda, K., Wahren, B.
-
Journal Title
Description
「研究成果報告書概要(欧文)」より
-
-
-
-
-
-
-
[Journal Article] A DNA vaccine containing inverted terminal repeats from adeno-associated virus increases immunity to HIV2003
Author(s)
Xin, K.-Q., Ooki, T., Jounai, N., Mizukami, H., Hamajima, K., Kojima, Y., Ohba, K., Toda, Y,.Hirai, S., Klinman, D.M., Ozawa, K., Okuda, K.
-
Journal Title
J Gene Med 5
Pages: 438-445
Description
「研究成果報告書概要(欧文)」より
-
[Journal Article] Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env2003
Author(s)
Xin, K.-Q., Hoshino, Y., Toda, Y., Igimi, S., Kojima, Y., Jounai, N., Ohba, K., Kushiro, A., Kiwaki, M., Hamajima, K., Klinman, D., Okuda, K.
-
Journal Title
Description
「研究成果報告書概要(欧文)」より
-
[Journal Article] Contribution of the rev gene to the immunogenicity of DNA vaccines targetting the envelope glycoprotein of HIV2003
Author(s)
Jounai, N., Okuda, K., Kojima, Y., Toda, Y., Hamajima, K., Ohba, K., Klinman, D., Xin, K.-Q.
-
Journal Title
J Gene Med 5
Pages: 609-617
Description
「研究成果報告書概要(欧文)」より
-
[Journal Article] Chitin micro-particles (CMP) is a useful adjuvant for inducing viral specific immunity when delivered intranasally with an HIV-DNA vaccine2003
Author(s)
Hamajima, K., Kojima, Y., Matsui, K., Toda, Y., Jounai, N., Ozaki, T., Xin, K.-Q., Strong, P., Okuda, K.
-
Journal Title
Viral Immunol 16
Pages: 541-547
Description
「研究成果報告書概要(欧文)」より
-
-
-